Peter J. Ferguson

1.4k total citations
34 papers, 1.1k citations indexed

About

Peter J. Ferguson is a scholar working on Molecular Biology, Oncology and Biological Psychiatry. According to data from OpenAlex, Peter J. Ferguson has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Oncology and 3 papers in Biological Psychiatry. Recurrent topics in Peter J. Ferguson's work include Biochemical and Molecular Research (8 papers), DNA Repair Mechanisms (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Peter J. Ferguson is often cited by papers focused on Biochemical and Molecular Research (8 papers), DNA Repair Mechanisms (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Peter J. Ferguson collaborates with scholars based in Canada, United States and Japan. Peter J. Ferguson's co-authors include James Koropatnick, Yung-Chi Cheng, Ann F. Chambers, Elzbieta M. Kurowska, Mark Vincent, David Freeman, Carol E. Cass, M. H. FISHER, Joseph Stephenson and Bingsen Zhou and has published in prestigious journals such as PLoS ONE, Cancer Research and Journal of Nutrition.

In The Last Decade

Peter J. Ferguson

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter J. Ferguson Canada 17 639 377 228 219 92 34 1.1k
Sukta Das India 19 411 0.6× 202 0.5× 247 1.1× 196 0.9× 130 1.4× 43 1.0k
Xinmei Kang China 19 661 1.0× 286 0.8× 232 1.0× 333 1.5× 113 1.2× 29 1.5k
Sung‐Moo Kim South Korea 20 525 0.8× 205 0.5× 188 0.8× 92 0.4× 188 2.0× 33 1.2k
E A Hudson United Kingdom 14 720 1.1× 173 0.5× 174 0.8× 245 1.1× 65 0.7× 18 1.4k
Lokesh Dalasanur Nagaprashantha United States 15 581 0.9× 164 0.4× 122 0.5× 107 0.5× 67 0.7× 23 961
Shiau‐Chuen Cheah Malaysia 19 460 0.7× 198 0.5× 180 0.8× 128 0.6× 126 1.4× 40 1.2k
Govindaraj Sharmila India 15 508 0.8× 142 0.4× 163 0.7× 131 0.6× 70 0.8× 23 964
Mallikarjuna Gu United States 19 695 1.1× 115 0.3× 329 1.4× 164 0.7× 112 1.2× 22 1.3k
Sonia Emanuele Italy 25 1.0k 1.6× 298 0.8× 147 0.6× 149 0.7× 76 0.8× 51 1.8k
Koji Furuno Japan 16 388 0.6× 125 0.3× 129 0.6× 268 1.2× 74 0.8× 35 1.0k

Countries citing papers authored by Peter J. Ferguson

Since Specialization
Citations

This map shows the geographic impact of Peter J. Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Ferguson more than expected).

Fields of papers citing papers by Peter J. Ferguson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Ferguson. The network helps show where Peter J. Ferguson may publish in the future.

Co-authorship network of co-authors of Peter J. Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Ferguson. A scholar is included among the top collaborators of Peter J. Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Ferguson. Peter J. Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Figueredo, René, Meng Zhang, Peter J. Ferguson, et al.. (2020). CD5 blockade enhances ex vivo CD8 + T cell activation and tumour cell cytotoxicity. European Journal of Immunology. 50(5). 695–704. 28 indexed citations
2.
Ferguson, Peter J., Mark Vincent, & James Koropatnick. (2017). Synergistic Antiproliferative Activity of the RAD51 Inhibitor IBR2 with Inhibitors of Receptor Tyrosine Kinases and Microtubule Protein. Journal of Pharmacology and Experimental Therapeutics. 364(1). 46–54. 10 indexed citations
3.
Ferguson, Peter J., et al.. (2015). Synergistic Cytotoxicity against Human Tumor Cell Lines by Oncolytic Adenovirus dl1520 (ONYX-015) and Melphalan. Tumori Journal. 102(1). 31–39. 6 indexed citations
4.
Vareki, Saman Maleki, Di Chen, Peter J. Ferguson, et al.. (2015). IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells. PLoS ONE. 10(11). e0143435–e0143435. 34 indexed citations
5.
Figueredo, René, et al.. (2015). siRNA knockdown of mitochondrial thymidine kinase 2 (TK2) sensitizes human tumor cells to gemcitabine. Oncotarget. 6(26). 22397–22409. 7 indexed citations
6.
Leong, Hon S., Saman Maleki Vareki, René Figueredo, et al.. (2014). BRCA2 inhibition enhances cisplatin‐mediated alterations in tumor cell proliferation, metabolism, and metastasis. Molecular Oncology. 8(8). 1429–1440. 30 indexed citations
7.
Vareki, Saman Maleki, René Figueredo, Di Chen, et al.. (2014). Abstract 3765: Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, γ radiation, and cisplatin. Cancer Research. 74(19_Supplement). 3765–3765. 1 indexed citations
8.
Ferguson, Peter J., et al.. (2013). Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”. Molecular Therapy — Nucleic Acids. 2. e78–e78. 15 indexed citations
9.
Vareki, Saman Maleki, Peter J. Ferguson, René Figueredo, et al.. (2013). Abstract C77: A novel BRCA2 targeting antisense oligonucleotide sensitizes human tumor cells to chemotherapy and radiotherapy - the induction of ‘complementary lethality’ by targeting DNA repair.. Molecular Cancer Therapeutics. 12(11_Supplement). C77–C77. 1 indexed citations
10.
11.
Figueredo, René, et al.. (2011). Combining Small Interfering RNAs Targeting Thymidylate Synthase and Thymidine Kinase 1 or 2 Sensitizes Human Tumor Cells to 5-Fluorodeoxyuridine and Pemetrexed. Journal of Pharmacology and Experimental Therapeutics. 338(3). 952–963. 14 indexed citations
12.
Figueredo, René, et al.. (2008). ODN 491, a Novel Antisense Oligodeoxynucleotide That Targets Thymidylate Synthase, Exerts Cell-Specific Effects in Human Tumor Cell Lines. DNA and Cell Biology. 27(5). 229–240. 4 indexed citations
13.
14.
Ferguson, Peter J., et al.. (2007). Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Letters. 251(1). 168–178. 201 indexed citations
15.
Ferguson, Peter J., Elzbieta M. Kurowska, David J. Freeman, Ann F. Chambers, & James Koropatnick. (2006). In Vivo Inhibition of Growth of Human Tumor Lines by Flavonoid Fractions From Cranberry Extract. Nutrition and Cancer. 56(1). 86–94. 66 indexed citations
16.
Ferguson, Peter J., Elzbieta M. Kurowska, David Freeman, Ann F. Chambers, & James Koropatnick. (2004). A Flavonoid Fraction from Cranberry Extract Inhibits Proliferation of Human Tumor Cell Lines. Journal of Nutrition. 134(6). 1529–1535. 187 indexed citations
17.
Berg, Randal W., Melanie Werner, Peter J. Ferguson, et al.. (2001). Tumor Growth Inhibition in Vivo and G2/M Cell Cycle Arrest Induced by Antisense Oligodeoxynucleotide Targeting Thymidylate Synthase. Journal of Pharmacology and Experimental Therapeutics. 298(2). 477–484. 17 indexed citations
18.
Ferguson, Peter J., Olga Collins, Nicholas M. Dean, et al.. (1999). Antisense down‐regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5‐FUdR, 5‐FU and Tomudex in HeLa cells. British Journal of Pharmacology. 127(8). 1777–1786. 37 indexed citations
19.
Ferguson, Peter J., et al.. (1988). Combined modalities of resistance in etoposide-resistant human KB cell lines.. PubMed. 48(21). 5956–64. 131 indexed citations
20.
Ferguson, Peter J. & Yung-Chi Cheng. (1987). Transient protection of cultured human cells against antitumor agents by 12-O-tetradecanoylphorbol-13-acetate.. PubMed. 47(2). 433–41. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sukta Das Breakdown of academic impact, for papers by Xinmei Kang Breakdown of academic impact, for papers by Sung‐Moo Kim Breakdown of academic impact, for papers by E A Hudson Breakdown of academic impact, for papers by Lokesh Dalasanur Nagaprashantha Breakdown of academic impact, for papers by Shiau‐Chuen Cheah Breakdown of academic impact, for papers by Govindaraj Sharmila Breakdown of academic impact, for papers by Mallikarjuna Gu Breakdown of academic impact, for papers by Sonia Emanuele Breakdown of academic impact, for papers by Koji Furuno
Rankless by CCL
2026